RDNT (Health Care Services) Stock Valuation & Fair Value Significantly overvalued
RDNT (Health Care Services) trades at a blended P/E of 145.8, about 159% above its historical normal valuation, with a forward growth estimate of 55.7% and a PEG of 2.62. Analysts' one-year estimates have been hit 10% of the time.
Valuation flags
- Overvalued by 159%
Frequently asked questions
Is RDNT overvalued?
At a blended P/E of 145.8 versus its historical normal P/E of 56.2, RDNT trades about 159% above its typical valuation, with a PEG of 2.62 on 55.7% forward growth. tickerseer currently rates it significantly overvalued.
What is RDNT's fair value and PEG?
RDNT trades at a blended P/E of 145.8 against a historical normal P/E of 56.2, a PEG of 2.62, and a forward growth estimate of 55.7%.
Has tickerseer's rating of RDNT changed?
tickerseer's rating has been significantly overvalued since 2026-08-07.
Industry: Health Care Services. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.
Get the free weekly earnings preview
One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.
It's free, and you can unsubscribe any time. Educational content, not investment advice.